Elixir Pharmaceuticals' Series E Round

Elixir Pharmaceuticals raised a round of funding on May 25, 2009.

Elixir Pharmaceuticals a Cambridge MA-based biopharmaceutical company focuses on developing and commercializing drugs to treat and prevent metabolic disease and age-related diseases.…

Articles about Elixir Pharmaceuticals' Series E Round: